Success after medication depends on how well you can manage the return of your natural hunger signals
In 2018, Eli Lilly entered into a collaboration agreement with Chugai and paid a $50 million upfront payment to obtain the rights to clinically develop Orforglipron for the treatment of type 2 diabetes
If burping and associated symptoms significantly impair quality of life or interfere with treatment adherence, patients should discuss this with their provider rather than discontinuing medication independently
In this article, we'll explore the mechanics of these drugs, what to expect if you stop using them, and the steps to take for a safe transition once you've achieved your weight goal
Treated animals show significant improvements in body composition without changes in food intake
The shaded range on the chart represents the approximate 25th to 75th percentile of outcomes, giving you a sense of the typical spread rather than just the average